Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Miten, Mehta"'
Publikováno v:
Expert Opinion on Drug Delivery. 16:1333-1353
Introduction: With increasing use of biological products and devices, importance of human factor (HF) studies is increasing. The HF study ensures safe and effective use of the device by intended users, for intended uses, under intended use environmen
Publikováno v:
Journal of medical engineeringtechnology. 45(7)
Drug-device combination products should be safe and effective for intended uses by intended users under intended use environment during human factor (HF) studies. All known use errors and use-related problems should be considered during design of dev
Autor:
Rajiv Kumar, Navin Khattry, Dievya Gohil, Deepak Sharma, Beamon Agarwal, Vikram Gota, Dhruv Jha, Santosh K. Sandur, Rahul Checker, Anuradha Majumdar, Miten Mehta
Publikováno v:
International immunopharmacology. 84
Acute Graft versus Host Disease (aGVHD) is a frequent and serious complication in patients receiving allogeneic bone marrow transplantation (allo-BMT) and often requires rigorous prophylaxis. The current treatment regimens for aGVHD are associated wi
Autor:
Rajesh Kumar Singh, Anil Kumar Shukla, Mangal S. Nagarsenker, Anand Patil, Shilpa N. Patere, Miten Mehta, Vikash Kumar Dubey, Vikram Gota, Pankaj O. Pathak
Publikováno v:
AAPS PharmSciTech. 18:710-720
Surface modification of liposomes with targeting ligands is known to improve the efficacy with reduced untoward effects in treating infective diseases like visceral leishmaniasis (VL). In the present study, modified ligand (ML), designed by modifying
Publikováno v:
Regulatory Toxicology and Pharmacology. 107:104415
Nonclinical animal studies are considered as an integral part of biosimilar development program to demonstrate similarity and safety. We have compiled, reviewed and summarized animal studies conducted for European Medicines Agency (EMA) and United St
Publikováno v:
Journal of Biomedical Nanotechnology. 9:1996-2006
The current work was aimed to develop Medium Chain Triglyceride (MCT) rich self nanoemulsifying preconcentrate of paclitaxel (PTX) for parenteral delivery. Very high concentrations of Cremophor EL and ethanol in Taxol have rendered patients to severe
Publikováno v:
International journal of pharmaceutics. 472(1-2)
Several molecular inheritances have severely restrained the peroral delivery of taxanes. The main objective of the present investigation was to develop a paclitaxel (PTX) formulation which can circumvent the hurdles of its extremely poor solubility a
Publikováno v:
Journal of biomedical nanotechnology. 9(12)
The current work was aimed to develop Medium Chain Triglyceride (MCT) rich self nanoemulsifying preconcentrate of paclitaxel (PTX) for parenteral delivery. Very high concentrations of Cremophor EL and ethanol in Taxol have rendered patients to severe